AVBP Operating Cash Flow (Statement)
Arrivent Biopharma Inc · Operating Cash Flow (Statement)
AVBP Operating Cash Flow (Statement)
Latest reported-$147.93Mperiod ending
AVBP Cash from Operations (-$12.59M → -$147.93M)
Annual operating cash flow (statement)
High-resolution chart · PNG
AVBP operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -160,588,000 | |
| -70,212,000 | |
| -55,842,000 | |
| -43,631,000 | |
| -12,587,000 |